Global Preimplantation Genetics Diagnosis (PGD) Market Report By Test Type (Chromosomal Abnormalities, Gender Selection, X-linked Diseases, Aneuploidy, Single Gene Disorders, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212936
July 2020
Report Formats:

The global demand for Preimplantation Genetics Diagnosis (PGD) Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Preimplantation genetic diagnosis (PGD) identifies genetic abnormalities or defects in preimplantation embryos before embryo transfer. The diagnostic serves to prevent transmission of certain genetic diseases or disorders on to the child, so only unaffected embryos are established from in vitro fertilization (IVF).  Individuals with carriers of sex-linked genetic diseases and single-gene disorders, chromosomal disorders, women age 35 and over, women experiencing recurrent pregnancy loss, and women with more than one failed fertility treatment are possible candidates for PGD.       
 
Market Dynamics
 
The global preimplantation genetics diagnosis (PGD) market is projected to grow significantly during the forecast period owing to the rising incidences of hereditary, genetic, and chromosomal diseases. PGD is evolving as a promising technique to prevent the substantial risk of transmitting a severe genetic disorder to their offspring. The market is projected to see gradual growth owing to rising warenes about its benefits. Significant improvements in PGD analysis, such as fluorescence in situ hybridization (FISH), to newer molecular tools, such as DNA microarrays and next-generation sequencing will create new opportunities for the market. However, the high costs incurred in the PGD procedure hinder the growth of the market. Moreover, ethical concerns also obstruct the growth of the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of preimplantation genetics diagnosis (PGD).
 
Market Segmentation
 
The entire preimplantation genetics diagnosis (PGD) market has been sub-categorized into test type. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Test Type

  • Chromosomal Abnormalities
  • Gender Selection
  • X-linked Diseases
  • Aneuploidy
  • Single Gene Disorders
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for preimplantation genetics diagnosis (PGD) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Preimplantation Genetics Diagnosis (PGD) Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preimplantation genetics diagnosis (PGD) market include Reprogenetics, LLC, Genea Limited, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Genesis Genetics Ltd., Reproductive Genetics Innovations LLC. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Preimplantation Genetics Diagnosis (PGD) Market
       2.2. Global Preimplantation Genetics Diagnosis (PGD) Market Snapshot
 
3 . PREIMPLANTATION GENETICS DIAGNOSIS (PGD) – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Preimplantation Genetics Diagnosis (PGD) Market
       3.3. Market Restraints of Preimplantation Genetics Diagnosis (PGD) Market
       3.4. Opportunities of Preimplantation Genetics Diagnosis (PGD) Market
       3.5. Trends of Preimplantation Genetics Diagnosis (PGD) Market
       3.6. Porter’s Five Force Analysis of Preimplantation Genetics Diagnosis (PGD) Market
       3.7. Preimplantation Genetics Diagnosis (PGD) Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Test Type
           3.7.2 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Preimplantation Genetics Diagnosis (PGD) Value Chain Analysis
       4.2. Preimplantation Genetics Diagnosis (PGD) Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Preimplantation Genetics Diagnosis (PGD) Raw Material Manufactures List
           4.2.3. Price Trend of Preimplantation Genetics Diagnosis (PGD) Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Preimplantation Genetics Diagnosis (PGD) Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Preimplantation Genetics Diagnosis (PGD) Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Preimplantation Genetics Diagnosis (PGD) Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Preimplantation Genetics Diagnosis (PGD) Market
 
6 . GLOBAL PREIMPLANTATION GENETICS DIAGNOSIS (PGD) MARKET ANALYSIS BY TEST TYPE
       6.1 Overview by Test Type
       6.2 Historical Data 2015-2018
       6.3 Global Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type
       6.4 Market Analysis of Chromosomal Abnormalities by Regions
       6.6 Market Analysis of Gender Selection by Regions
       6.5 Market Analysis of X-linked Diseases by Regions
       6.7 Market Analysis of Aneuploidy by Regions
       6.8 Market Analysis of Single Gene Disorders by Regions
       6.9 Market Analysis of Others by Regions
 
7 . GLOBAL PREIMPLANTATION GENETICS DIAGNOSIS (PGD) MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview and Historic Data
           7.3.2. North America Preimplantation Genetics Diagnosis (PGD) Market Estimate By Market Segment
           7.3.3. North America Preimplantation Genetics Diagnosis (PGD) Market Estimate By Country
           7.3.4. United State
           7.3.5. Canada
           7.3.6. Mexico
       7.4. Europe
           7.4.1. Overview and Historic Data
           7.4.2. Europe Preimplantation Genetics Diagnosis (PGD) Market Estimate by Market Segment
           7.4.3. Europe Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7. Italy
           7.4.8. Russia
           7.4.9. Rest Of Europe
       7.5. Asia Pacific
           7.5.1. Overview and Historic Data
           7.5.2. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Estimate by Market Segment
           7.5.3. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country
           7.5.4. China
           7.5.5. India
           7.5.6. Japan
           7.5.7. South Korea
           7.5.8. Australia
           7.5.9. Rest Of Asia Pacific
       7.6. Latin America
           7.6.1. Overview and Historic Data
           7.6.2. Latin America Preimplantation Genetics Diagnosis (PGD) Market Estimate by Market Segment
           7.6.3. Latin America Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Argentina
           7.6.6. Peru
           7.6.7. Chile
           7.6.8. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview and Historic Data
           7.7.2. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Estimate by Market Segment
           7.7.3. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country
           7.7.4. Saudi Arabia
           7.7.5. UAE
           7.7.6. Israel
           7.7.7. South Africa
           7.7.8. Rest Of Middle East And Africa
 
8 . COMPETITIVE LANDSCAPE OF THE PREIMPLANTATION GENETICS DIAGNOSIS (PGD) COMPANIES
       8.1. Preimplantation Genetics Diagnosis (PGD) Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF PREIMPLANTATION GENETICS DIAGNOSIS (PGD) INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Reprogenetics, LLC
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Genea Limited
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Illumina, Inc.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Laboratory Corporation of America Holdings
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Natera, Inc.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. PerkinElmer, Inc.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Quest Diagnostics Incorporated
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Genesis Genetics Ltd.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Reproductive Genetics Innovations LLC
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Preimplantation Genetics Diagnosis (PGD) Market Snapshot
  • Drivers of The Global Preimplantation Genetics Diagnosis (PGD) Market Impact Analysis
  • Restraints of The Global Preimplantation Genetics Diagnosis (PGD) Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Preimplantation Genetics Diagnosis (PGD) Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Preimplantation Genetics Diagnosis (PGD) Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Preimplantation Genetics Diagnosis (PGD) Market
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Historic Data 2015-2018
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Chromosomal Abnormalities by Geography ( USD MN)
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Gender Selection by Geography ( USD MN)
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in X-linked Diseases by Geography ( USD MN)
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Aneuploidy by Geography ( USD MN)
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Single Gene Disorders by Geography ( USD MN)
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Others by Geography ( USD MN)
  • Global Preimplantation Genetics Diagnosis (PGD) Market by Geography ( USD MN)
  • Historic Data 2015-2018
  • North America Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • North America Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country ( USD MN)
  • United State Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Canada Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Mexico Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Europe Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Europe Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country ( USD MN)
  • United Kingdom Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • France Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Germany Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Italy Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Russia Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Spain Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country ( USD MN)
  • China Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Japan Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • India Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • South Korea Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Australia Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Latin America Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Latin America Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country ( USD MN)
  • Brazil Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Argentina Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Peru Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Chile Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Rest of Latin America Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Estimate by Country ( USD MN)
  • Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • UAE Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Israel Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • South Africa Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Rest of Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type ( USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Preimplantation Genetics Diagnosis (PGD) Report
  • Market Research Process
  • Market Research Methodology
  • Global Preimplantation Genetics Diagnosis (PGD) Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Test Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis by Test Type
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Chromosomal Abnormalities by Region
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Gender Selection by Region
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in X-linked Diseases by Region
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Aneuploidy by Region
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Single Gene Disorders by Region
  • Global Preimplantation Genetics Diagnosis (PGD) Market Analysis in Others by Region
  • Global Preimplantation Genetics Diagnosis (PGD) Market by Revenue
  • North America Preimplantation Genetics Diagnosis (PGD) Market by Revenue
  • Europe Preimplantation Genetics Diagnosis (PGD) Market by Revenue
  • Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Revenue
  • Latin America Preimplantation Genetics Diagnosis (PGD) Market by Revenue
  • Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market by Revenue
  • Recent Development in Preimplantation Genetics Diagnosis (PGD) Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials